Skip to main content
Log in

Severe autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemia responsive to fludarabine-based treatment

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Bastion Y, Coiffier B, Dumontet C, et al. (1992) Severe autoimmune hemolytic anemia in two patients treated with fludarabine for chronic lymphocytic leukemia. Ann Oncol 3: 171–173

    Google Scholar 

  2. Foon KA, Rai KR, Gale RP (1990) Chronic lymphocytic leukemia: new insights into biology and therapy. Ann Intern Med 113: 525–539

    Google Scholar 

  3. Grever M, Leiby J, Kraut E, et al. (1990) A comprehensive phase-I and -II clinical investigation of fludarabine phosphate. Semin Oncol 17 [Suppl 8]: 39–48

    Google Scholar 

  4. Keating MJ (1990) Fludarabine phosphate in the treatment of chronic lymphocytic leukemia. Semin Oncol 17 [Suppl 8]: 49–62

    Google Scholar 

  5. Keating MJ, Kantarjian H, Talpaz M, et al. (1989) Fludarabine: a new agent with major acitivity against chronic lymphocytic leukemia. Blood 74: 19–25

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported by C.N.R., Progetto Finalizzato A.C.R.O., Contract No. 92.02125, PF 39

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tosti, S., Caruso, R., D'Adamo, F. et al. Severe autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemia responsive to fludarabine-based treatment. Ann Hematol 65, 238–239 (1992). https://doi.org/10.1007/BF01703953

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01703953

Keywords

Navigation